Press Releases

Date Description  
Nov 3, 2016
Cogentix Medical Shareholders Approve $25 Million Equity Investment
Shareholders Also Approve Transactions Converting Debt to Equity All Transactions Have Closed Today Proceeds Provide Resources to Execute Urology Focused Business Development Strategy MINNEAPOLIS, MN, November 3, 2016 – Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device company that
Oct 27, 2016
Cogentix Medical to Report Third Quarter Results on November 8, 2016
MINNEAPOLIS , Oct. 27, 2016 /PRNewswire/ -- Cogentix Medical, Inc. ( NASDAQ : CGNT), a medical device company that develops, manufactures and markets innovative proprietary products for the urology market, will release financial results for the third quarter ended September 30, 2016 after the
Sep 20, 2016
Cogentix Medical to Participate in the Ladenburg Thalmann 2016 Healthcare Conference
MINNEAPOLIS , Sept. 20, 2016 /PRNewswire/ -- Cogentix Medical , Inc. ( NASDAQ : CGNT), a medical device company that develops, manufactures and markets innovative proprietary products for the urology market, today announced that it will participate in the Ladenburg Thalmann 2016 Healthcare
Sep 7, 2016
Cogentix Medical Enters Into Definitive Agreement For $25 Million Equity Investment

Proceeds to Provide Resources to Execute Urology Focused Business Development Strategy<br>Proposed Equity Investment at 29% Premium to Market<br>All Current Outstanding Debt to be Converted into Common Shares

Aug 2, 2016
Cogentix Medical Reports 17 Percent Q2 Revenue Growth

Company Successfully Executing Growth Strategies<br>Third Consecutive Quarter of Cash Operating Profit<br>Cash Balance Increases Sequentially<br>Conference Call Today at 4:30 pm ET

Jul 20, 2016
Cogentix Medical to Report Second Quarter Results on August 2, 2016
MINNEAPOLIS , July 20, 2016 /PRNewswire/ --  Cogentix Medical, Inc. ( NASDAQ : CGNT), a global medical device company with innovative and proprietary products serving urology and airway management markets, will release financial results for the second quarter ended June 30, 2016 after the market
Jul 12, 2016
Darin Hammers Appointed President And CEO Of Cogentix Medical, Inc.
MINNEAPOLIS , July 12, 2016 /PRNewswire/ --  Cogentix Medical, Inc.  ( NASDAQ : CGNT), a global medical device company with innovative and proprietary products serving urology and airway management markets, today announced that Darin Hammers has been appointed President and Chief Executive
Jun 22, 2016
Healthcare Industry Leader Kenneth A. Samet Joins Cogentix Medical Board of Directors
MINNEAPOLIS , June 22, 2016 /PRNewswire/ -- Cogentix Medical , Inc. ( NASDAQ : CGNT), a global medical device company with innovative and proprietary products serving urology and airway management markets, today announced that Kenneth A. Samet has been appointed as a new independent director to the
Jun 15, 2016
Brett Reynolds Rejoins Cogentix Medical As Chief Financial Officer
MINNEAPOLIS , June 15, 2016 /PRNewswire/ -- Cogentix Medical , Inc. ( NASDAQ : CGNT), a global medical device company with innovative and proprietary products serving urology and airway management markets, today reported that Brett A. Reynolds has rejoined the company as Senior Vice President,
May 24, 2016
Cogentix Medical Announces Settlement Agreement in Connection with Proxy Contest and Related Litigation and Leadership Changes; Annual Meeting To Be Held May 24, 2016 at 12:00 P.M. Central Daylight Time
Cogentix Medical Announces Settlement Agreement in Connection with Proxy Contest and Related Litigation and Leadership Changes; Annual Meeting To Be Held May 24, 2016 at 12:00 P.M. Central Daylight Time MINNEAPOLIS, May 24, 2016 /PRNewswire/ -- Cogentix Medical, Inc.
Displaying 21 - 30 of 74